Correction: Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome

Published Erratum

Roberta Fusco et al. PLoS One. 2018.

. 2018 Jul 25;13(7):e0201501.

doi: 10.1371/journal.pone.0201501. eCollection 2018.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0178553.].

Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
Fusco R, Gugliandolo E, Campolo M, Evangelista M, Di Paola R, Cuzzocrea S. Fusco R, et al. PLoS One. 2017 Jun 8;12(6):e0178553. doi: 10.1371/journal.pone.0178553. eCollection 2017. PLoS One. 2017. PMID: 28594885 Free PMC article.

1. Fusco R, Gugliandolo E, Campolo M, Evangelista M, Di Paola R, Cuzzocrea S (2017) Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome. PLoS ONE 12(6): e0178553 10.1371/journal.pone.0178553 - DOI - PMC - PubMed
1. Impellizzeri D, Bruschetta G, Cordaro M, Crupi R, Siracusa R, Esposito E, et al. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. Journal of neuroinflammation. 2014;11:136 10.1186/s12974-014-0136-0 ; PubMed Central PMCID: PMC4171547. - DOI - PMC - PubMed
1. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. Journal of basic and clinical pharmacy. 2016; 7(2):27±31. 10.4103/0976-0105.177703 ; PubMed Central PMCID: PMC4804402. - DOI - PMC - PubMed